Pharmacotherapy for Hyperglycemia in Pregnancy - Do Oral Agents have a Place?
Gestational diabetes mellitus (GDM) is associated with short[1,2] and long term adverse outcomes for both mother[3] and offspring, throughout childhood and into adulthood[4 –7]. Long term risks for the offspring include various features of the metabolic syndrome, such as obesity, adiposity, insulin resistance and type 2 diabetes mellitus, all of which may create and intergenerational vicious cycle of metabolic derangement[8]. Hyperglycemia during pregnancy is instrum ental for this perpetuation, with publications indicating its role in type 1[9] and monogenic diabetes[10].
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Rosa Corcoy, Montserrat Balsells, Apolonia Garc ía-Patterson, Anat Shmueli, Eran Hadar Tags: Review Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 1 | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Insulin | Metabolic Syndrome | Obesity | Pregnancy